ATM Expression and Activation in Ataxia Telangiectasia Patients with and without Class Switch Recombination Defects
Journal of Clinical Immunology · 2025-12 · 45 (1)
DOI: 10.1007/s10875-025-01857-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Immunology, online erschienen am 24.01.2025. Verfasst von Fereshte Salami und 18 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children´s Medical Center, Tehran University of Medical Sciences, 62 Qarib S…. Hauptthemen laut MEDLINE: Ataxia Telangiectasia, Ataxia Telangiectasia Mutated Proteins, Immunoglobulin Class Switching. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Karolinska Institute.
Abstract (Originalsprache)
Background
Ataxia telangiectasia mutated (ATM) kinase plays a critical role in DNA double-strand break (DSB) repair. Ataxia telangiectasia (A-T) patients exhibit abnormalities in immunoglobulin isotype expression and class switch recombination (CSR). This study investigates the role of residual ATM kinase expression and activity in the severity of A-T disease.
Methods
A-T patients with defined genetic diagnoses were classified based on CSR and based on the severity of their medical complications. Isolated peripheral blood mononuclear cells from any patient were evaluated before and after exposure to 0.5 Gy ionizing radiation for one minute. Western blotting was performed to identify the expression of ATM and phosphorylated ATM (p-ATM) proteins compared to age-sex-matched healthy controls.
Results
In severe A-T patients ( n = 6), the majority (66.7%) had frameshift mutations, while 33.3% had nonsense mutations in the ATM gene. The mild group ( n = 3) had two cases of splice errors and one missense mutation. All patients with CSR defect had elevated IgM serum levels, whereas all switched immunoglobulins were reduced in them. Expression of ATM and p-ATM proteins was significantly lower ( p = 0.01) in all patients compared to healthy controls, both pre-and post- and post-radiation. Additionally, low ATM and p-ATM protein expression levels were linked with the clinical severity of patients but were not correlated with CSR defects.
Conclusion
Expression and activation of ATM protein were defective in A-T patients compared to healthy controls. Altered expression of ATM and p-ATM proteins may have potential clinical implications for prognostic evaluation and symptom severity assessment in individuals with A-T.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children´s Medical Center, Tehran University of Medical Sciences, 62 Qarib St., Keshavarz Blvd, Tehran, 14194, Iran.
- Primary Immunodeficiency Diseases Network (PIDNet), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
- Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians- Universität München (LMU), Munich, Germany.
- Medical Genetics Network (Megene), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
- Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Radiotherapy Oncology, Cancer Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Förderung
- Karolinska Institute
Zitieren
APA
Salami, F., Shad, T. M., Fathi, N., Mojtahedi, H., Esmaeili, M., Shahkarami, S., Afrakoti, L. G. M. P., Amirifar, P., Delavari, S., Nosrati, H., Razavi, A., Ranjouri, M. R., Yousefpour, M., Esfahani, Z. H., Azizi, G., Ashrafi, M., Rezaei, N., Yazdani, R., & Abolhassani, H. (2025). ATM Expression and Activation in Ataxia Telangiectasia Patients with and without Class Switch Recombination Defects. Journal of Clinical Immunology, 45(1). https://doi.org/10.1007/s10875-025-01857-3
Vancouver
Salami F, Shad TM, Fathi N, Mojtahedi H, Esmaeili M, Shahkarami S, et al. ATM Expression and Activation in Ataxia Telangiectasia Patients with and without Class Switch Recombination Defects. Journal of Clinical Immunology. 2025;45(1). doi:10.1007/s10875-025-01857-3
BibTeX
@article{Salami2025,
author = {Salami, Fereshte and Shad, Tannaz Moeini and Fathi, Nazanin and Mojtahedi, Hanieh and Esmaeili, Marzie and Shahkarami, Sepideh and Afrakoti, Ladan Gol Mohammad Pour and Amirifar, Parisa and Delavari, Samaneh and Nosrati, Hassan and Razavi, Azadehsadat and Ranjouri, Mohammad Reza and Yousefpour, Mahsa and Esfahani, Zahra Hamidi and Azizi, Gholamreza and Ashrafi, Mahmoudreza and Rezaei, Nima and Yazdani, Reza and Abolhassani, Hassan},
title = {ATM Expression and Activation in Ataxia Telangiectasia Patients with and without Class Switch Recombination Defects},
journal = {Journal of Clinical Immunology},
year = {2025},
volume = {45},
number = {1},
doi = {10.1007/s10875-025-01857-3}
}
EUVIMED